<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>26</volume><submitter>Yamamoto R</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>To elucidate the association between blood glucose levels at the return of spontaneous circulation (ROSC) and neurological outcomes following out-of-hospital cardiac arrest (OHCA), a post hoc analysis was conducted using data from a prospective observational study involving 41 hospitals in Tokyo and its suburbs from 2019 to 2021. Adults with nontraumatic OHCA who achieved ROSC were included.&lt;h4>Methods&lt;/h4>A total of 1533 patients were analyzed. A spline curve for estimating neurological outcomes (Cerebral Performance Category score ≤2 at 30 days) by blood glucose level at ROSC was generated. Patients were classified into low, moderate, and high blood glucose groups, defined as &lt;100, 100-300, and ≥300 mg/dL, respectively. Neurological outcomes were compared using generalized estimating equations adjusted for patient and institutional characteristics.&lt;h4>Results&lt;/h4>Favorable neurologic outcomes were fewer in the low and high blood glucose groups than in the moderate group (8/132 [6.1 %] and 62/485 [12.8 %] vs. 181/807 [22.4 %]). The adjusted model revealed that low and high glucose levels at ROSC were associated with fewer favorable outcomes (odds ratios, 0.43 [0.18-0.96] and 0.59 [0.42-0.84]). High blood glucose levels showed unfavorable effects in subgroups with cardiogenic or noncardiogenic etiology, age &lt;65 years, and low-flow time ≤30 min, whereas low blood glucose levels showed unfavorable effects only in cardiogenic cases.&lt;h4>Conclusions&lt;/h4>Blood glucose levels &lt;100 and ≥300 mg/dL were associated with unfavorable neurological outcomes, with a nonlinear inverted U-shaped relationship.</pubmed_abstract><journal>Resuscitation plus</journal><pagination>101088</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12481122</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Blood glucose upon return of spontaneous circulation and neurological outcomes following out-of-hospital cardiac arrest.</pubmed_title><pmcid>PMC12481122</pmcid><pubmed_authors>Sasaki J</pubmed_authors><pubmed_authors>Matsumura K</pubmed_authors><pubmed_authors>Suzuki M</pubmed_authors><pubmed_authors>Kaito D</pubmed_authors><pubmed_authors>Yasunaga H</pubmed_authors><pubmed_authors>Yamamoto R</pubmed_authors><pubmed_authors>Kitamura N</pubmed_authors><pubmed_authors>Homma K</pubmed_authors><pubmed_authors>SOS-KANTO 2017 Study Group</pubmed_authors><pubmed_authors>Nomura T</pubmed_authors><pubmed_authors>Aso S</pubmed_authors><pubmed_authors>Tagami T</pubmed_authors><pubmed_authors>Tamura T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Blood glucose upon return of spontaneous circulation and neurological outcomes following out-of-hospital cardiac arrest.</name><description>&lt;h4>Background&lt;/h4>To elucidate the association between blood glucose levels at the return of spontaneous circulation (ROSC) and neurological outcomes following out-of-hospital cardiac arrest (OHCA), a post hoc analysis was conducted using data from a prospective observational study involving 41 hospitals in Tokyo and its suburbs from 2019 to 2021. Adults with nontraumatic OHCA who achieved ROSC were included.&lt;h4>Methods&lt;/h4>A total of 1533 patients were analyzed. A spline curve for estimating neurological outcomes (Cerebral Performance Category score ≤2 at 30 days) by blood glucose level at ROSC was generated. Patients were classified into low, moderate, and high blood glucose groups, defined as &lt;100, 100-300, and ≥300 mg/dL, respectively. Neurological outcomes were compared using generalized estimating equations adjusted for patient and institutional characteristics.&lt;h4>Results&lt;/h4>Favorable neurologic outcomes were fewer in the low and high blood glucose groups than in the moderate group (8/132 [6.1 %] and 62/485 [12.8 %] vs. 181/807 [22.4 %]). The adjusted model revealed that low and high glucose levels at ROSC were associated with fewer favorable outcomes (odds ratios, 0.43 [0.18-0.96] and 0.59 [0.42-0.84]). High blood glucose levels showed unfavorable effects in subgroups with cardiogenic or noncardiogenic etiology, age &lt;65 years, and low-flow time ≤30 min, whereas low blood glucose levels showed unfavorable effects only in cardiogenic cases.&lt;h4>Conclusions&lt;/h4>Blood glucose levels &lt;100 and ≥300 mg/dL were associated with unfavorable neurological outcomes, with a nonlinear inverted U-shaped relationship.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-04T00:13:06.232Z</modification><creation>2026-05-03T03:12:14.263Z</creation></dates><accession>S-EPMC12481122</accession><cross_references><pubmed>41035570</pubmed><doi>10.1016/j.resplu.2025.101088</doi></cross_references></HashMap>